Response to "ACE-2 Downregulation and Incidence of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) Infection"
Am J Hypertens
.
2021 Apr 20;34(4):427.
doi: 10.1093/ajh/hpaa212.
Authors
Sascha Dublin
1
2
,
Rod L Walker
1
,
James S Floyd
1
2
3
,
Susan M Shortreed
1
4
,
Sharon Fuller
1
,
Ladia Albertson-Junkans
1
,
Laura B Harrington
1
2
,
Mikael Anne Greenwood-Hickman
1
,
Beverly B Green
1
,
Bruce M Psaty
2
3
5
Affiliations
1
Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
2
Department of Epidemiology, University of Washington, Seattle, Washington, USA.
3
Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA.
4
Department of Biostatistics, University of Washington, Seattle, Washington, USA.
5
Department of Health Services, University of Washington, Seattle, Washington, USA.
PMID:
33320177
PMCID:
PMC7799315
DOI:
10.1093/ajh/hpaa212
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Down-Regulation
Humans
Incidence
SARS-CoV-2*
Grants and funding
R01 HL142599/HL/NHLBI NIH HHS/United States